PMED — Peptonic Medical AB Share Price
Last trade - 00:00- SEK23.04m
- SEK22.65m
- SEK26.89m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.47 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.86 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -120.79% | ||
| Return on Equity | -96.92% | ||
| Operating Margin | -218.1% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 35.2 | 31.64 | 43.63 | 37.12 | 26.89 | n/a | n/a | 43.57% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Peptonic Medical AB is a Sweden-based company active in the field of biotechnology. The Company develops estrogen-free pharmaceuticals for treatment of vaginal atrophy. The Company's main drug candidate is Vagitocin, an oxytocin-based pharmaceutical preparation for the treatment of vaginal atrophy and other menopause-related symptoms. The patented treatment is based on local, vaginal application of oxytocin to rejuvenate the vaginal mucosa. Vagitocin is to enter phase III clinical trials in Europe and the United States.
Directors
- Hans von Celsing CHM
- Erik Sundquist CEO (51)
- Dan Markusson COO (57)
- Kerstin Uvnas Moberg CSO
- Mikael Svensson GMG
- Leni Ekendahl DRC
- Marianne Ostlund DRC
- Arne Ferstad NED
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 31st, 2009
- Public Since
- July 2nd, 2014
- No. of Employees
- 7
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- AktieTorget Stock Exchange
- Shares in Issue
- 5,759,303,014
- Address
- Gustavslundsvagen 143, BROMMA, 167 51
- Web
- https://www.peptonicmedical.se/
- Phone
- +46 853020110
- Auditors
- KPMG AB
Upcoming Events for PMED
Similar to PMED
Abera Bioscience AB
AktieTorget Stock Exchange
Aptahem AB
AktieTorget Stock Exchange
Bio-Works Technologies AB
AktieTorget Stock Exchange
Carbiotix AB (publ)
AktieTorget Stock Exchange
Chosa Oncology AB
AktieTorget Stock Exchange
FAQ
As of Today at 22:36 UTC, shares in Peptonic Medical AB are trading at SEK0.00. This share price information is delayed by 15 minutes.
Shares in Peptonic Medical AB last closed at SEK0.00 and the price had moved by -63.99% over the past 365 days. In terms of relative price strength the Peptonic Medical AB share price has underperformed the FTSE Global All Cap Index by -64.89% over the past year.
There is no consensus recommendation for this security.
Find out morePeptonic Medical AB does not currently pay a dividend.
Peptonic Medical AB does not currently pay a dividend.
Peptonic Medical AB does not currently pay a dividend.
To buy shares in Peptonic Medical AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SEK0.00, shares in Peptonic Medical AB had a market capitalisation of SEK23.04m.
Here are the trading details for Peptonic Medical AB:
- Country of listing: Sweden
- Exchange: AKT
- Ticker Symbol: PMED
Based on an overall assessment of its quality, value and momentum Peptonic Medical AB is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Peptonic Medical AB. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -23.18%.
As of the last closing price of SEK0.00, shares in Peptonic Medical AB were trading -20.03% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Peptonic Medical AB PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Peptonic Medical AB's management team is headed by:
- Hans von Celsing - CHM
- Erik Sundquist - CEO
- Dan Markusson - COO
- Kerstin Uvnas Moberg - CSO
- Mikael Svensson - GMG
- Leni Ekendahl - DRC
- Marianne Ostlund - DRC
- Arne Ferstad - NED